Save up -80% on Rivaroxaban
Note: this is a drug discount program, not an insurance plan.
2018 Price of Rivaroxaban
* price without discount in nearest pharmacy. Price may vary.
We offer free Rivaroxaban coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Rivaroxaban every time. What are you waiting for? Claim your prescription drug card now!
Rivaroxaban volume of distribution
The steady state Vd is 50 L
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Rivaroxaban
Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary. However there is no antidote available in the event of a major bleed. Only the 10 mg tablet can be taken without regard to food. The 15 mg and 20 mg tablet should be taken with food. FDA approved on July 1, 2011.
Rivaroxaban mechanism of action
Rivaroxaban competitively inhibits free and clot bound factor Xa. Factor Xa is needed to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process. Since one molecule of factor Xa can generate more than 1000 molecules of thrombin, selective inhibitors of factor Xa are profoundly useful in terminating the amplification of thrombin generation. The action of rivaroxaban is irreversible.
Dosage forms of Rivaroxaban
|Film-coated tablet||Oral use||10 mg|
|Film-coated tablet||Oral use||15 mg|
|Film-coated tablet||Oral use||2.5 mg|
BAY 59-7939 BAY59-7939
Humans and other mammals
Indication of Rivaroxaban
Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Due to a lack of safety studies, it is not recommended for use in those under 18 years old. Its use is also not recommended in those with severe renal impairment (30mL/min).
Toxicity of Rivaroxaban
Excessive bleeding. Overdosages should be treated using activated charcoal and supportive measures such as mechanical compression and hemodynamic support. If bleeding is not controlled, the following procoagulants can be administered: activated prothrombin complex concentrate, prothrombin complex concentrate and recombinant factor VIIa. There is also a higher chance of post procedural hemorrhage compared to enoxaparin (1.55% vs. 1.39% respectively).
RX24 Drugs Disclaimer: before buying a Rivaroxaban on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.